RECRUITINGOBSERVATIONAL
Giessen Pulmonary Hypertension in Lung Cancer Registry
About This Trial
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patient with lung cancer at the University of Giessen lung Cancer Center.
Who Should NOT Join This Trial:
\-
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patient with lung cancer at the University of Giessen lung Cancer Center.
Exclusion Criteria:
\-
Treatments Being Tested
OTHER
All lung cancer patients.
There will be no specific interventions. All patients will receive guidelines based therapy of lung cancer and their comorbidities.
Locations (1)
University hospital Giessen
Giessen, Hesse, Germany